IDH1 and glioblastoma: The major changes were driven by IDH mutation status and included the restriction of the diagnosis of GBM to tumors that are IDH wild type; tumors previously diagnosed as IDH-mutated GBMs were reclassified as astrocytoma IDH mutated, grade 4 [3].